Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) is now available.
Shanghai Haohai Biological Technology Co., Ltd. has scheduled a board meeting for March 21, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the recommendation for a final dividend, which could impact the company’s financial strategy and shareholder returns.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the biotechnology sector, focusing on the development and production of biological products.
YTD Price Performance: -0.56%
Average Trading Volume: 254,896
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$13.49B
For detailed information about 6826 stock, go to TipRanks’ Stock Analysis page.